Skip to main content
. 2015 May 12;2(2):ofv070. doi: 10.1093/ofid/ofv070

Table 3.

Factors Associated With Incident Anogenital Warts Among 1104 High-Risk Men in Kenya

Characteristics and Behaviors Warts/Per PY Incidence/100 PY (95% CI) Bivariate Analysis
Multivariate Analysis
Hazard Ratio (95% CI) Wald P Value Adjusted Hazard Ratio (95% CI) Wald P Value
Age group .10
 18–24 yr 34/485.2 7.0 (5.0–9.8) Referent
 25–34 yr 40/803.5 5.0 (3.7–6.8) 0.71 (.45–1.12)
 >34 yr 13/358.4 3.6 (2.1–6.2) 0.52 (.27–.99)
Genital syndrome at current visita,b <.001 <.001
 No 47/1390.4 3.4 (2.5–4.5) Referent Referent
 Yes 40/256.7 15.6 (11.4–21.2) 5.10 (3.27–7.95) 4.78 (3.03–7.56)
HIV-1 status (serologic testing) .09 .04
 Uninfected 63/1330.7 4.7 (3.7–6.1) Referent Referent
 Infected 24/316.4 7.6 (5.1–11.3) 1.50 (.94–2.41) 1.66 (1.01–2.72)
Circumcised (physical examination finding) .15
 No 11/130.5 8.4 (4.7–15.2) Referent
 Yes 76/1493.3 5.1 (4.1–6.4) 0.61 (.32–1.14)
Education .26
 Primary or lower 39/864.0 4.5 (3.3–6.2) Referent
 Secondary 40/624.7 6.4 (4.7–8.7) 1.45 (.93–2.26)
 Higher/tertiary 8/158.4 5.1 (2.5–10.1) 1.20 (.57–2.58)
Ever married .06 .23
 No 68/1130.9 6.0 (4.7–7.6) Referent Referent
 Yes 19/516.2 3.7 (2.3–5.8) 0.62 (.37–1.04) 0.71 (.42–1.23)
Employment .78
 None 21/413.3 5.1 (3.3–7.8) Referent
 Self 42/797.4 5.3 (3.9–7.1) 1.12 (.66–1.90)
 Formal 24/436.4 5.5 (3.7–8.2) 1.23 (.68–2.22)
Use of any soap in past week (self report)a .28 .49
 No 6/66.2 9.1 (4.1–20.2) Referent Referent
 Yes 79/1567.5 5.0 (4.0–6.3) 0.61 (.26–1.40) 0.74 (.32–1.74)
Soap dose in past week (self report)a .58
 None (did not use soap at all) 6/66.2 9.1 (4.1–20.2) Referent
 1 (1–7 times/week) 16/335.9 4.8 (2.9–7.8) 0.57 (.22–1.45)
 2 (8–14 times/week) 44/949.8 4.6 (3.4–6.2) 0.57 (.24–1.34)
 3 (15–21 times/week) 17/270.6 6.3 (3.9–10.1) 0.71 (.28–1.83)
Number of sex partners in past montha .23
 None 16/384.0 4.2 (2.6–6.8) Referent
 1 18/473.7 3.8 (2.4–6.0) 0.85 (.43–1.68)
 2–4 29/525.5 5.5 (3.8–7.9) 1.13 (.60–2.11)
 >4 24/263.8 9.1 (6.1–13.6) 1.60 (.83–3.13)
Condom use for anal sex in past weeka .21
 No anal sex 39/921.6 4.2 (3.1–5.8) Referent
 All protected 11/100.8 10.9 (6.0–19.7) 1.90 (.96–3.78)
 Any unprotected 37/624.7 5.9 (4.3–8.2) 1.07 (.67–1.72)
Condom use for any sexual activity in past weeka .47
 No sexual activity 33/640.6 5.2 (3.7–7.2) Referent
 All protected 20/454.8 4.4 (2.8–6.8) 0.81 (.46–1.40)
 Any unprotected 34/549.1 6.2 (4.4–8.7) 1.13 (.70–1.83)
Group sex in past 3 moa .28
 No 76/1531 5.0 (4.0–6.2) Referent
 Yes 9/102.8 8.8 (4.6–16.8) 1.50 (.75–3.02)
Sex work in past 3 moa,c .025 .26
 No 38/1003.2 3.8 (2.8–5.2) Referent Referent
 Yes 47/630.7 7.5 (5.6–9.9) 1.65 (1.06–2.57) 1.31 (.82–2.11)
Gender of sex partners in past 3 moa .053 .61
 Men and women 65/1130.2 5.8 (4.5–7.3) Referent Referent
 Only men 13/158.8 8.2 (4.8–14.1) 1.45 (.79–2.64) 0.88 (.46–1.70)
 Only women 9/358.1 2.5 (1.3–4.8) 0.48 (.21–1.06) 0.68 (.30–1.53)
Alcohol use in past montha .36
 None 8/209.5 3.8 (1.9–7.6) Referent
 None with sex 38/805.6 4.7 (3.4–6.5) 0.74 (.30–1.84)
 Yes with sex 39/618.7 6.3 (4.6–8.6) 1.02 (.42–2.47)
Insertive anal sex in past weeka .65
 No 58/1133.3 5.1 (4.0–6.6) Referent
 Yes 29/513.8 5.6 (3.9–8.1) 0.90 (.57–1.42)
 Receptive anal sex in past weeka .13
 No 49/1118.1 4.4 (3.3–5.8) Referent
 Yes 38/529.0 7.2 (5.2–9.9) 1.40 (.90–2.16)

Abbreviations: CI, confidence interval; HIV, human immunodeficiency virus; PMNs, polymorphonuclear cells; PY, person-years.

aUpdated at each visit.

bDefined as having a diagnosis of urethritis (defined as 5 or more PMNs per high-power field on a Gram-stained urethral smear), proctitis (defined as 5 or more PMNs per high-power field on a Gram-stained rectal smear), or genital ulceration (any ulceration, either penile or perianal, on physical exam).

cSex work was defined as having received cash, living expenses, or goods in exchange for sex.